Sunshine Nuohuo: Clinical trial application for ABA001 injection approved

Sunshine Nuohuo Announcement, recently, the company and its wholly owned subsidiary Beijing Arna Technology Co., Ltd. received the “Drug Clinical Trial Approval Notice” issued by the National Medical Products Administration, approving the clinical trial application for the company’s research project ABA001 injection. This drug is a Class 1 innovative drug, with the proposed indication being hypertension.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments